Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruki Kaku

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Time to normalization of testosterone after withdrawal of long time LH-RH agonist therapy in prostate cancer]Haruki Kaku, Tomoyasu Tsushima, Yasutomo Nasu, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Suicide gene and immuno gene therapy for prostate cancer]Yasutomo Nasu, Katsumi Sasaki, Hiromi Kumon, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[REIC/Dkk-3 gene therapy]Masami Watanabe, Haruki Kaku, Peng Huang, et al.
Japanese Journal of Clinical Oncology|December 25, 2002
Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapyTakashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, et al.
Acta Medica Okayama|January 17, 2004
Anterior urethral recurrence of superficial bladder cancer: its clinical significanceTakashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, et al.
The Prostate|December 6, 2005
Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancerHaruki Kaku, Takashi Saika, Tomoyasu Tsushima, et al.
Urology|July 13, 2004
Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinomaHaruki Kaku, Sachio Ito, Shin Ebara, et al.
Cancer Genomics & Proteomics|January 13, 2010
A comparison of proteomic profiles changes during 17beta-estradiol treatment in human prostate cancer PC-3 cell lineJie Chen, Peng Huang, Haruki Kaku, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2007
Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapyYasutomo Nasu, Takashi Saika, Shin Ebara, et al.
Acta Medica Okayama|March 2, 2006
Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancerHaruki Kaku, Takashi Saika, Tomoyasu Tsushima, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Time to normalization of testosterone after withdrawal of long time LH-RH agonist therapy in prostate cancer]Haruki Kaku, Tomoyasu Tsushima, Yasutomo Nasu, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Suicide gene and immuno gene therapy for prostate cancer]Yasutomo Nasu, Katsumi Sasaki, Hiromi Kumon, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[REIC/Dkk-3 gene therapy]Masami Watanabe, Haruki Kaku, Peng Huang, et al.
Japanese Journal of Clinical Oncology|December 25, 2002
Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapyTakashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, et al.
Acta Medica Okayama|January 17, 2004
Anterior urethral recurrence of superficial bladder cancer: its clinical significanceTakashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, et al.
The Prostate|December 6, 2005
Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancerHaruki Kaku, Takashi Saika, Tomoyasu Tsushima, et al.
Urology|July 13, 2004
Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinomaHaruki Kaku, Sachio Ito, Shin Ebara, et al.
Cancer Genomics & Proteomics|January 13, 2010
A comparison of proteomic profiles changes during 17beta-estradiol treatment in human prostate cancer PC-3 cell lineJie Chen, Peng Huang, Haruki Kaku, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2007
Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapyYasutomo Nasu, Takashi Saika, Shin Ebara, et al.
Acta Medica Okayama|March 2, 2006
Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancerHaruki Kaku, Takashi Saika, Tomoyasu Tsushima, et al.
Pageof 4